|
RAB6A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.23319999995242E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.06400000032814E-07 |
| Normal-vs-Stage2 |
3.397100E-03 |
| Normal-vs-Stage3 |
7.310400E-02 |
| Normal-vs-Stage4 |
4.501300E-03 |
| Stage1-vs-Stage2 |
4.961000E-01 |
| Stage1-vs-Stage3 |
8.600400E-02 |
| Stage1-vs-Stage4 |
8.435200E-01 |
| Stage2-vs-Stage3 |
5.059800E-01 |
| Stage2-vs-Stage4 |
7.785600E-01 |
| Stage3-vs-Stage4 |
4.470200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.78819999708102E-08 |
| Normal-vs-AfricanAmerican |
1.561030E-03 |
| Normal-vs-Asian |
8.722100E-02 |
| Caucasian-vs-AfricanAmerican |
1.651370E-01 |
| Caucasian-vs-Asian |
5.156200E-01 |
| AfricanAmerican-vs-Asian |
9.003000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.06460001819886E-09 |
| Normal-vs-Female |
1.646050E-01 |
| Male-vs-Female |
1.554200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.410800E-04 |
| Normal-vs-Extreme_Weight |
3.08140002402979E-09 |
| Normal-vs-Obese |
1.420580E-03 |
| Normal-vs-Extreme_Obese |
3.212200E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.261840E-01 |
| Normal_Weight-vs-Obese |
5.438800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.309800E-01 |
| Extreme_Weight-vs-Obese |
9.175300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.107200E-01 |
| Obese-vs-Extreme_Obese |
2.955200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.920200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.154910E-04 |
| Normal-vs-Age(61-80Yrs) |
2.85540002753493E-09 |
| Normal-vs-Age(81-100Yrs) |
3.8849000000063E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.622390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.640300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.558200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.837000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.529360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.542600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.10219996755035E-09 |
| Normal-VS-Type2 PRCC |
1.50749999999755E-05 |
| Normal-VS-KIRP CIMP |
1.335760E-01 |
| Normal-VS-Unclassified PRCC |
3.877700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.628400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.97050000047849E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
5.815600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.782400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.746050E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.116130E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.61990000045054E-07 |
| Normal-vs-N1 |
1.308570E-01 |
| Normal-vs-N2 |
2.574000E-02 |
| N0-vs-N1 |
3.532100E-02 |
| N0-vs-N2 |
8.615400E-01 |
| N1-vs-N2 |
4.858200E-01 |
|
|
